Qualys, Inc Q4 Profit Increases, Beats Estimates

Qualys delivered a solid Q4 with GAAP EPS of $1.47 ($53.15M) versus $1.19 last year and revenue of $175.28M, up 10.1% from $159.19M; adjusted EPS was $1.87 and topped the street $1.78 consensus. Management issued Q1 revenue guidance of $172.5M–$174.5M and EPS $1.76–$1.83, and FY26 guidance of $717M–$725M revenue and $7.17–$7.45 EPS, signaling continued top-line growth and profitability expansion for the cybersecurity software vendor.

Analysis

Market structure: Qualys's beat and FY26 guide (rev $717–725M; EPS $7.17–7.45) signal steady SaaS subscription demand with low churn — wins accrue to cloud-native vulnerability management vendors (QLYS, TENB) and managed security service providers; losers are legacy appliance vendors that face pricing pressure. The modest sequential EPS guidance (Q1 $1.76–1.83 vs. adj Q4 $1.87) implies demand is stable but not accelerating, preserving current pricing power rather than enabling a re-rating; expect 5–15% share shifts within mid-market accounts over 12–24 months if Qualys converts more endpoint and cloud workloads.

Risk assessment: Key tail risks are (1) enterprise IT spend pullback from a macro recession (10–20% probability over 12 months) that hits renewals, (2) a major security breach undermining customer trust, and (3) aggressive discounting by larger rivals (PANW/CRWD) compressing ARR yields. Near-term (days-weeks) price volatility will follow guidance replay and options vol; medium-term (3–12 months) execution on cross-sell and ARR expansion matters most; long-term (12–36 months) depends on cloud workload coverage and integration with SIEM/XDR ecosystems.

Trade implications: Tactical direct play: establish a 2–3% portfolio long in QLYS (ticker QLYS) targeting +15–25% in 6–12 months if quarterly ARR/renewal metrics beat by >200–300bps; set stop-loss at -10% from entry. Pair trade: long QLYS / short TENB (1:1 notional) to isolate execution on vulnerability management versus peers. Options: buy 4–6 month 25% OTM calls or sell 45–60 day 5–7% OTM puts to collect premium if willing to be assigned; avoid long-dated straddles until post next-quarter guidance volatility subsides.

Contrarian angles: Consensus prices steady growth; overlooked is potential margin expansion — if SG&A grows <5% YoY while revenue grows ~10%+, EPS could surprise above high guide, producing 10–20% upside. Conversely, the market may under-price the risk of enterprise spend tightening; a <2% QoQ revenue slip in two consecutive quarters should trigger re-evaluation. Historical parallels: mid-cap SaaS names that delivered consistent subscription beats have re-rated sharply after 2–3 consecutive quarters of ARR outperformance, so monitor renewal rates and large-ticket bookings as early signals.

Key Decisions for Investors

• Establish a 2–3% long position in QLYS within the next 5 trading days, target +15–25% upside over 6–12 months if upcoming quarterly ARR/renewal metrics exceed guidance by >200bps; implement a hard stop-loss at -10% from entry.
• Initiate a pair trade: long QLYS / short TENB (equal dollar exposure) for 3–9 months to play execution on vulnerability management; trim the pair if QLYS revenue growth decelerates by >200bps QoQ or TENB reports superior ARR expansion.
• Use options tactically: buy 4–6 month QLYS calls at ~25% OTM (size 25–50% of equivalent stock exposure) to leverage upside if guidance-driven re-rating occurs, or sell 45–60 day 5–7% OTM puts to collect premium and potentially acquire stock at a ~6% discount to market if assigned.
• Reduce marginal exposure to higher-multiple, momentum cybersecurity names (e.g., ZS, CRWD) by 1–2% of portfolio in favor of quality execution names like QLYS if macro indicators (ISM Services <50 or U.S. payroll surprises) signal IT spend contraction within 60–90 days.